AbbVie to Present Data at the 2026 European Society for Medical Oncology Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio
New and updated data across seven assets in lung, colorectal, ovarian, prostate and gastric cancers underscore the potential…
#Europe #EU #ABBV #European #nyse-abbv #pharmaceutical-investing
https://www.europesays.com/europe/161843/